medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Número 2

<< Anterior Siguiente >>

Ann Hepatol 2017; 16 (2)


Identification of Matrix Metalloproteinase-2 and 9 as Biomarker of Intrahepatic Cholestasis of Pregnancy

Chen Z, Shen Z, Hu L, Lu M, Feng Y

Idioma: Ingles.
Referencias bibliográficas: 33
Paginas: 291-296
Archivo PDF: 210.70 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009: 15: 2049-66.

  2. Reyes H. Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol 1997: 12: 211- 6.

  3. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004: 40: 467-74. doi: 10.1002/hep.20336.

  4. Nichols AA. Cholestasis of pregnancy: a review of the evidence. J Perinat Neonatal Nurs 2005: 19: 217-25.

  5. Reyes H, Radrigan ME, Gonzalez MC, Latorre R, Ribalta J, Segovia N, Alvarez C, et al. Steatorrhea in patients with intrahepatic cholestasis of pregnancy. Gastroenterology 1987: 93: 584-90.

  6. Mullally BA, Hansen WF. Intrahepatic cholestasis of pregnancy: review of the literature. Obstet Gynecol Surv 2002: 57: 47-52.

  7. Pusl T, Beuers U. Intrahepatic cholestasis of pregnancy. Orphanet J Rare Dis 2007: 2: 26. doi: 10.1186/1750-1172-2- 26.

  8. Riely CA, Bacq Y. Intrahepatic cholestasis of pregnancy. Clin Liver Dis 2004:8:167-76. doi: 10.1016/S1089- 3261(03)00131-4.

  9. Lee RH, Goodwin TM, Greenspoon J, Incerpi M. The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol 2006: 26: 527-32. doi: 10.1038/sj.jp.7211545.

  10. Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000: 33: 1012-21.

  11. Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology 2008: 47: 376-9. doi: 10.1002/hep.22139.

  12. Abedin P, Weaver JB, Egginton E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health 1999: 4: 35-7. doi: 10.1080/13557859998173.

  13. Beuers U, Pusl T. Intrahepatic cholestasis of pregnancy—a heterogeneous group of pregnancy-related disorders? Hepatology 2006: 43: 647-9. doi: 10.1002/hep.21156.

  14. Zhang L, Zhang F, Tang L, Yang W, Zhang X. Intrahepatic cholestasis of pregnancy and fetal injury. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2013: 38: 645-52. doi: 10.3969/ j.issn.1672-7347.2013.06.015.

  15. Li L, Zhao XY, Ou XJ, Jia JD. Clinical analysis of intrahepatic cholestasis of pregnancy. Zhonghua Gan Zang Bing Za Zhi 2013: 21: 295-8. doi: 10.3760/cma.j.issn.1007- 3418.2013.04.013.

  16. Pathak B, Sheibani L, Lee RH. Cholestasis of pregnancy. Obstet Gynecol Clin North Am 2010:37:269-82. doi: 10.1016/j.ogc.2010.02.011.

  17. Heikkinen J, Maentausta O, Tuimala R, Ylostalo P, Janne O. Amniotic fluid bile acids in normal and pathologic pregnancy. Obstet Gynecol 1980: 56: 60-4.

  18. Laatikainen T, Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 1984: 22: 91-4.

  19. Rodrigues CM, Marin JJ, Brites D. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment. Gut 1999: 45: 446-52.

  20. Meng LJ, Reyes H, Axelson M, Palma J, Hernandez I, Ribalta J, Sjövall J, et al. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Hepatology 1997: 26: 1573-9. doi: 10.1002/hep.510260627.

  21. Brites D, Rodrigues CM, van-Zeller H, Brito A, Silva R. Relevance of serum bile acid profile in the diagnosis of intrahepatic cholestasis of pregnancy in an high incidence area: Portugal. Eur J Obstet Gynecol Reprod Biol 1998: 80: 31-8.

  22. Mays JK. The active management of intrahepatic cholestasis of pregnancy. Curr Opin Obstet Gynecol 2010: 22: 100-3. doi: 10.1097/GCO.0b013e328337238d.

  23. Huang WM, Gowda M, Donnelly JG. Bile acid ratio in diagnosis of intrahepatic cholestasis of pregnancy. Am J Perinatol 2009: 26: 291-4. doi: 10.1055/s-0028-1103158.

  24. Qi HB, Shao Y, Wu WX, Zhang JH. Grading of intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 2004: 39: 14-7.1

  25. Mashige F, Imai K, Osuga T. A simple and sensitive assay of total serum bile acids. Clin Chim Acta 1976: 70: 79-86.

  26. Feldmann D, Fenech C, Cuer JF. Evaluation of a samplepreparation procedure for bile acids in serum and bile. Clin Chem 1983: 29: 1694.

  27. Koucký M, Germanová A, Kalousová M, Hill M, Cindrová-Davies T, Parízek A, Svarcová J, et al. Low maternal serum matrix metalloproteinase (MMP)-2 concentrations are associated with preterm labor and fetal inflammatory response. J Perinat Med 2010: 38: 589-96. doi: 10.1515/ JPM.2010.092.

  28. Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, Becker A, et al. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail 2008:10:861-8. doi: 10.1016/j.ejheart.2008.07.005.

  29. Stojanovic N, Lewandowski K, Salata I, Bienkiewicz M, Tuck S, Prelevic G, Press M., et al. Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls. Gynecol Endocrinol 2010:26:201-7. doi: 10.1080/ 09513590902972026.

  30. Montagnana M, Lippi G, Albiero A, Scevarolli S, Salvagno GL, Franchi M, Guidi GC, et al. Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy. J Clin Lab Anal 2009:23:88-92. doi: 10.1002/jcla.20295.

  31. Wang Z, Lu S, Liu C, Zhao B, Pei K, Tian L, Ma X, et al. Expressional and epigenetic alterations of placental matrix metalloproteinase 9 in preeclampsia. Gynecol Endocrinol 2010: 26: 96-102. doi: 10.3109/09513590903184100.

  32. Merchant SJ, Crocker IP, Baker PN, Tansinda D, Davidge ST, Guilbert LJ. Matrix metalloproteinase release from placental explants of pregnancies complicated by intrauterine growth restriction. J Soc Gynecol Investig 2004: 11: 97-103. doi: 10.1016/j.jsgi.2003.08.005.

  33. Fortunato SJ, Menon R, Lombardi SJ. Amniochorion gelatinase- gelatinase inhibitor imbalance in vitro: a possible infectious pathway to rupture. Obstet Gynecol 2000: 95: 240-4.




2020     |     www.medigraphic.com